Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Treasury Shares (2016 - 2025)

Mimedx's Treasury Shares history spans 14 years, with the latest figure at $1000.0 for Q1 2023.

  • On a quarterly basis, Treasury Shares fell 99.88% to $1000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $1000.0, a 99.88% decrease, with the full-year FY2021 number at $4.0 million, down 46.07% from a year prior.
  • Treasury Shares hit $4.7 million in Q4 2025 for Mimedx, up from $4.2 million in the prior quarter.
  • Over the last five years, Treasury Shares for MDXG hit a ceiling of $4.7 million in Q4 2025 and a floor of $334.0 in Q1 2023.
  • Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $777869.0 in 2021.
  • Biggest five-year swings in Treasury Shares: skyrocketed 187.17% in 2020 and later plummeted 99.93% in 2022.
  • Tracing MDXG's Treasury Shares over 5 years: stood at $10.8 million in 2019, then tumbled by 31.07% to $7.4 million in 2020, then crashed by 46.07% to $4.0 million in 2021, then plummeted by 99.83% to $7000.0 in 2022, then crashed by 85.71% to $1000.0 in 2023.
  • Business Quant data shows Treasury Shares for MDXG at $1000.0 in Q1 2023, $7000.0 in Q3 2022, and $3000.0 in Q2 2022.